Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
|Articles|September 14, 2018
Isolator and Filling Machine for Vials
groninger and SKAN have collaborated to develop Integra, a production line concept that integrates both an isolator and filling machine for vials with a large capacity range.
groninger and SKAN have collaborated to develop Integra, a production line concept that integrates both an isolator and filling machine for vials with a large capacity range.
The product was developed with a focus on processing toxic products. Features include shorter decontamination cycles and simplified cleaning. The integration of the filling machine into the isolator and the integration of the SKANFOG decontamination system allows the line to be cleaned and decontaminated in approximately 30 minutes with accessibility for operating personnel, according to groninger. Increased security and support for format changes enabled by the use of quick response codes gives operators a better overview of position, installation order, and recipe selection.
Different line configurations are available with either standardized open restricted access barrier systems or isolator modules and are capable of a maximum production output of 400 vials per minute, groninger reports.
Related to this article
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.